1![MEDA Pharmaceuticals Pty Ltd Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information MEDA Pharmaceuticals Pty Ltd Elidel® Cream Pimecrolimus 1 % w/w Consumer Medicine Information](https://www.pdfsearch.io/img/7d25998722367876a9a290a69a301a61.jpg) | Add to Reading ListSource URL: www.meda.co.nzLanguage: English - Date: 2016-03-15 20:00:13
|
---|
2![New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream Presentation New Zealand Datasheet Name of Medicine ELIDEL® Pimecrolimus 1% Cream Presentation](https://www.pdfsearch.io/img/20e7d01529ef6dc8b0e5fad680a63ef2.jpg) | Add to Reading ListSource URL: www.meda.co.nzLanguage: English - Date: 2016-03-15 20:00:14
|
---|
3![](https://www.pdfsearch.io/img/da6d4ab6a035a201d6b497fbf6b17efd.jpg) | Add to Reading ListSource URL: www.nottingham.ac.ukLanguage: English - Date: 2013-08-14 15:00:15
|
---|
4![Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1 TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology Journal of IMAB - Annual Proceeding (Scientific Papers) 2008, book 1 TREATMENT OF PSORIASIS VULGARIS WITH ELIDEL S. Racheva, R. Bachvarova, J. Dimitrova Department and clinic of dermatovenerology](https://www.pdfsearch.io/img/4160ef22643985a84372c5dfb3cf4b60.jpg) | Add to Reading ListSource URL: www.journal-imab-bg.orgLanguage: English - Date: 2010-05-18 03:05:54
|
---|
5![TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe TOPICAL IMMUNOMODULATOR CRITERIA Pharmacology: Pimecrolimus inhibits the calcium-dependent phosphatase (calcineurin), interfering with T-cell activation and transcription of early cytokines. Thus, it decreases the synthe](https://www.pdfsearch.io/img/2266ba6a832124615a3e48d666f6801d.jpg) | Add to Reading ListSource URL: www.nhhealthyfamilies.comLanguage: English - Date: 2014-09-11 16:48:58
|
---|
6![Atopic Dermatitis Personalized Management Plan Patient Name:_____________________________________________________ Date:_______________________________ Healthcare provider:________________________________________________ Atopic Dermatitis Personalized Management Plan Patient Name:_____________________________________________________ Date:_______________________________ Healthcare provider:________________________________________________](https://www.pdfsearch.io/img/80d09df7f7295aecb73d867b732a21b1.jpg) | Add to Reading ListSource URL: www.aaaai.orgLanguage: English - Date: 2014-09-30 16:23:12
|
---|
7![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIDEL® safely and effectively. See full prescribing information for ELIDEL®. ELIDEL® (pimecrolimus) Cream, 1% fo HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ELIDEL® safely and effectively. See full prescribing information for ELIDEL®. ELIDEL® (pimecrolimus) Cream, 1% fo](https://www.pdfsearch.io/img/c155df4245e3ef96e6303609b3f42dac.jpg) | Add to Reading ListSource URL: elidel-us.comLanguage: English - Date: 2014-06-19 10:56:32
|
---|
8![Atopic dermatitis: A practice parameter update 2012 Atopic dermatitis: A practice parameter update 2012](https://www.pdfsearch.io/img/adc752ad90fc63bbd78cceda16392896.jpg) | Add to Reading ListSource URL: www.aaaai.orgLanguage: English - Date: 2013-02-06 16:22:16
|
---|
9![NDA[removed]S-011 Page 3 Elidel® (pimecrolimus) Cream 1% FOR DERMATOLOGIC USE ONLY NDA[removed]S-011 Page 3 Elidel® (pimecrolimus) Cream 1% FOR DERMATOLOGIC USE ONLY](https://www.pdfsearch.io/img/295e49740031022b05121143ac2a81cb.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2009-03-31 14:55:22
|
---|
10![ELIDEL® (pimecrolimus) Cream, 1% ELIDEL® (pimecrolimus) Cream, 1%](https://www.pdfsearch.io/img/de690775e41f9d438c26529800b7a8ec.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|